Resmed Inc. buy Mizuho
Start price
13.04.23
/
50%
€203.30
Target price
13.04.24
-
Performance (%)
-13.63%
End price
14.04.24
€175.60
Summary
This prediction ended on 14.04.24 with a price of €175.60. The prediction for Resmed Inc. disappointed with a performance of -13.63%. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. A total of €1.73 was paid as dividends for this prediction. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 2.832% | 2.832% | -5.448% |
| iShares Core DAX® | 0.597% | 3.083% | 16.090% |
| iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% |
| iShares Nikkei 225® | 1.775% | -1.206% | 6.823% |
| iShares S&P 500 | 0.990% | 3.500% | 24.956% |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at Mizuho. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten